EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Opportunities for Machine Learning and Artificial Intelligence to Advance Synthetic Drug Substance Process Development

Daniel J. Griffin, Connor W. Coley, Scott A. Frank, Joel M. Hawkins, Klavs F. Jensen

Organic Process Research & Development · 17.11.2023 · 27 (11) · 1868-1879

DOI: 10.1021/acs.oprd.3c00229 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Organic Process Research & Development, online erschienen am 25.09.2023. Verfasst von Daniel J. Griffin und 4 weiteren Autor:innen. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Griffin, D. J., Coley, C. W., Frank, S. A., Hawkins, J. M., & Jensen, K. F. (2023). Opportunities for Machine Learning and Artificial Intelligence to Advance Synthetic Drug Substance Process Development. Organic Process Research & Development, 27(11), 1868-1879. https://doi.org/10.1021/acs.oprd.3c00229

Vancouver

Griffin DJ, Coley CW, Frank SA, Hawkins JM, Jensen KF. Opportunities for Machine Learning and Artificial Intelligence to Advance Synthetic Drug Substance Process Development. Organic Process Research & Development. 2023;27(11):1868-1879. doi:10.1021/acs.oprd.3c00229

BibTeX
@article{Griffin2023,
  author = {Griffin, Daniel J. and Coley, Connor W. and Frank, Scott A. and Hawkins, Joel M. and Jensen, Klavs F.},
  title = {Opportunities for Machine Learning and Artificial Intelligence to Advance Synthetic Drug Substance Process Development},
  journal = {Organic Process Research & Development},
  year = {2023},
  volume = {27},
  number = {11},
  pages = {1868--1879},
  doi = {10.1021/acs.oprd.3c00229}
}
Kostenlos starten →